Opendata, web and dolomites

Gasgon SIGNED

Development of a Novel Medical Device to Remove Air Bubbles from Medicines, Which Will Improve Patient Safety and Reduce Costs of IV Infusion

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Gasgon project word cloud

Explore the words cloud of the Gasgon project. It provides you a very rough idea of what is the project "Gasgon" about.

heart    brain    intensive    entering    medications    majority    mechanical    outcomes    invented    automatic    financial    disruptive    receiving    vent    sepsis    man    stroke    gas    break    treatment    wasted    treatments    removing    extreme    line    alarms    performance    over    air    block    healthcare    billion    220mn    fluids    regardless    dysfunction    potentially    patient    efficacy    place    global    filters    innovation    strain    medical    intravenous    blocking    electronic    reliably    optimise    fluid    environment    unsuitable    clinicians    patients    attack    remove    complications    reducing    human    health    first    position    solutions    infusion    venous    gasgon    puts    opportunity    serious    unmet    bubble    hours    acts    embolism    labour    prescribed    pending    positively    inpatients    bubbles    enter    risk    80    blood    adverse    clinical    form    reduce    burden    deadly    intervene    flow    patent    medicine    dose    disposable    complication    death    providers    interrupting    globally    infusions    carry    market   

Project "Gasgon" data sheet

The following table provides information about the project.

Coordinator
TESSEN SOLUTIONS LIMITED 

Organization address
address: RUBICON CENTRE, BISHOPSTOWN. CO. CORK, IRELAND
city: Cork
postcode: n.a.
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2020-06-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TESSEN SOLUTIONS LIMITED IE (Cork) coordinator 50˙000.00

Map

 Project objective

Over 2 billion medical intravenous (IV) infusions occur each year globally, with over 80% of inpatients receiving IV treatment. Each of these infusions carry a serious health risk – the risk that gas bubbles enter with the fluid and block blood flow in patients. Air Embolism, a potentially deadly complication of IV infusion, is a result of bubbles entering the venous system and blocking blood flow leading to serious adverse complications for patients such as Sepsis, Stroke, Brain Dysfunction and Heart Attack. In extreme cases death can occur. Gasgon Medical has built a break-through and disruptive technology to reduce risk and optimise fluid management in common medical IV treatments. Currently clinicians must intervene to remove every bubble in every infusion, a labour-intensive practice that puts a strain on healthcare resources, with wasted man-hours and reduced efficacy of the medicine dose. Technology solutions on the market include electronic alarms and in-line filters – these are unsuitable in the majority of cases and place a significant human and financial burden on healthcare providers. Our innovation, which is a new form of ‘vent’ technology, will solve this unmet clinical need. Gasgon Medical has invented the first mechanical, in-line, automatic vent capable of removing bubbles from IV fluids regardless of position or environment. Our Patent-pending disposable vent acts quickly and reliably without interrupting or reducing the prescribed dose of medications. This represents a major technology advancement over current methods of managing risk in IV infusions. Gasgon Medical can lead a €220mn IV vent opportunity bringing an exciting European innovation to the global market. This novel Gasgon vent technology has the potential to positively impact healthcare delivery and performance, leading to better patient outcomes.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GASGON" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GASGON" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Dyme (2019)

Dyme gives its users complete control over their financial situation. The Dyme application provides insight into users’ spending and subscriptions, and lets users cancel, negotiate, or switch any cont

Read More  

QTB4AMR (2019)

Utilizing an innovative chemical platform to defeat antimicrobial resistance

Read More  

DeltaQon (2019)

IOT and cloud computing for online medical analysis service platform

Read More